v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid In Capital
Accumulated Deficit
Accumulated Other Comprehensive Gain (Loss)
Beginning Balance at Dec. 31, 2024 $ 835,619 $ 7 $ 1,591,707 $ (754,610) $ (1,485)
Shares, Outstanding, Beginning Balance at Dec. 31, 2024   64,890,193      
Issuance of Common Stock and accompanying Pre-Funded Warrants at Private Placement, net of issuance 237,294   237,294    
Issuance of Common Stock and accompanying pre-funded warrants at Private Placement, net of issuance cost, shares   5,044,500      
Issuance of shares under employee stock purchase plan, Shares   44,129      
Issuance of shares under employee stock purchase plan 1,112   1,112    
Exercise of stock options 8,237   8,237    
Exercise of stock options, Shares   353,738      
Vesting restricted stock, Shares   224,882      
Stock-based compensation expense 29,649   29,649    
Unrealized loss on marketable securities 1,764       1,764
Net loss (142,195)     (142,195)  
Ending Balance at Jun. 30, 2025 971,480 $ 7 1,867,999 (896,805) 279
Shares, Outstanding, Ending Balance at Jun. 30, 2025   70,557,442      
Beginning Balance at Mar. 31, 2025 786,233 $ 7 1,606,475 (820,191) (58)
Shares, Outstanding, Beginning Balance at Mar. 31, 2025   65,112,714      
Issuance of Common Stock and accompanying Pre-Funded Warrants at Private Placement, net of issuance 237,294   237,294    
Issuance of Common Stock and accompanying pre-funded warrants at Private Placement, net of issuance cost, shares   5,044,500      
Issuance of shares under employee stock purchase plan, Shares   44,129      
Issuance of shares under employee stock purchase plan 1,112   1,112    
Exercise of stock options 7,703   7,703    
Exercise of stock options, Shares   278,086      
Stock-based compensation expense 15,415   15,415    
Unrealized loss on marketable securities 337       337
Net loss (76,614)     (76,614)  
Ending Balance at Jun. 30, 2025 971,480 $ 7 1,867,999 (896,805) 279
Shares, Outstanding, Ending Balance at Jun. 30, 2025   70,557,442      
Beginning Balance at Dec. 31, 2025 1,579,664 $ 8 2,643,817 (1,065,961) 1,800
Shares, Outstanding, Beginning Balance at Dec. 31, 2025   81,323,532      
Vesting restricted stock, Shares   78,013      
Ending Balance at Mar. 31, 2026 1,539,637 $ 8 2,679,018 (1,135,195) (4,194)
Shares, Outstanding, Ending Balance at Mar. 31, 2026   82,182,101      
Beginning Balance at Dec. 31, 2025 1,579,664 $ 8 2,643,817 (1,065,961) 1,800
Shares, Outstanding, Beginning Balance at Dec. 31, 2025   81,323,532      
Issuance of shares under employee stock purchase plan, Shares   25,952      
Issuance of shares under employee stock purchase plan 1,472   1,472    
Exercise of stock options 32,577   32,577    
Exercise of stock options, Shares   1,188,166      
Vesting restricted stock, Shares   250,603      
Stock-based compensation expense 34,945   34,945    
Unrealized loss on marketable securities (8,957)       (8,957)
Net loss (130,445)     (130,445)  
Ending Balance at Jun. 30, 2026 1,509,256 $ 8 2,712,811 (1,196,406) (7,157)
Shares, Outstanding, Ending Balance at Jun. 30, 2026   82,788,253      
Beginning Balance at Mar. 31, 2026 1,539,637 $ 8 2,679,018 (1,135,195) (4,194)
Shares, Outstanding, Beginning Balance at Mar. 31, 2026   82,182,101      
Issuance of shares under employee stock purchase plan, Shares   25,952      
Issuance of shares under employee stock purchase plan 1,472   1,472    
Exercise of stock options 13,383   13,383    
Exercise of stock options, Shares   518,649      
Vesting restricted stock, Shares   61,551      
Stock-based compensation expense 18,938   18,938    
Unrealized loss on marketable securities 2,963       (2,963)
Net loss (61,211)     (61,211)  
Ending Balance at Jun. 30, 2026 $ 1,509,256 $ 8 $ 2,712,811 $ (1,196,406) $ (7,157)
Shares, Outstanding, Ending Balance at Jun. 30, 2026   82,788,253